Minerva Neurosciences reported $55.7M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Adma Biologics ADMA:US $ 239.8M 31.07M
ALKERMES ALKS:US 1.01B 47.34M
AstraZeneca AZN:LN 22.65B 3.6B
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Dynavax Technologies DVAX:US $ 940.52M 32.01M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Johnson & Johnson JNJ:US $ 60424M 555M
Marinus Pharmaceuticals MRNS:US $ 135.07M 3.39M
Merk MRK:US $ 31184M 918M
Minerva Neurosciences NERV:US $ 55.7M 6.5M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Novavax NVAX:US $ 2347.41M 192.29M
Pfizer PFE:US $ 54420M 5273M
Takeda 4502:JP Y 2593642M 115749M
Vanda Pharmaceuticals VNDA:US $ 492.27M 13.97M